Yield10 Bioscience Stock Current Ratio
| YTENDelisted Stock | USD 1.90 0.04 2.06% |
Yield10 Bioscience fundamentals help investors to digest information that contributes to Yield10 Bioscience's financial success or failures. It also enables traders to predict the movement of Yield10 Stock. The fundamental analysis module provides a way to measure Yield10 Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Yield10 Bioscience stock.
Yield10 |
Yield10 Bioscience Company Current Ratio Analysis
Yield10 Bioscience's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Yield10 Bioscience Current Ratio | 6.58 X |
Most of Yield10 Bioscience's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yield10 Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Yield10 Bioscience has a Current Ratio of 6.58 times. This is 71.8% higher than that of the Biotechnology sector and 191.15% higher than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
Yield10 Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Yield10 Bioscience's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Yield10 Bioscience could also be used in its relative valuation, which is a method of valuing Yield10 Bioscience by comparing valuation metrics of similar companies.Yield10 Bioscience is currently under evaluation in current ratio category among its peers.
Yield10 Fundamentals
| Return On Equity | -15.08 | ||||
| Return On Asset | -1.5 | ||||
| Operating Margin | (240.28) % | ||||
| Current Valuation | 3.96 M | ||||
| Shares Outstanding | 642.54 K | ||||
| Shares Owned By Insiders | 12.59 % | ||||
| Shares Owned By Institutions | 11.79 % | ||||
| Number Of Shares Shorted | 60.7 K | ||||
| Price To Earning | (3.19) X | ||||
| Price To Book | 11.23 X | ||||
| Price To Sales | 79.63 X | ||||
| Revenue | 60 K | ||||
| Gross Profit | (7.3 M) | ||||
| EBITDA | (14.13 M) | ||||
| Net Income | (14.46 M) | ||||
| Cash And Equivalents | 10.16 M | ||||
| Cash Per Share | 2.07 X | ||||
| Total Debt | 3.18 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | (4.95) X | ||||
| Cash Flow From Operations | (10.07 M) | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | (43.68) X | ||||
| Target Price | 2.5 | ||||
| Number Of Employees | 29 | ||||
| Beta | 1.7 | ||||
| Market Capitalization | 1.85 M | ||||
| Total Asset | 3.91 M | ||||
| Retained Earnings | (414.15 M) | ||||
| Working Capital | (3.46 M) | ||||
| Current Asset | 15.34 M | ||||
| Current Liabilities | 3.91 M | ||||
| Net Asset | 3.91 M |
About Yield10 Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Yield10 Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yield10 Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yield10 Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Yield10 Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Yield10 Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yield10 Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving against Yield10 Stock
| 0.81 | IPI | Intrepid Potash | PairCorr |
| 0.81 | IE | Ivanhoe Electric | PairCorr |
| 0.8 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.72 | MHGVY | Mowi ASA ADR | PairCorr |
| 0.67 | CTVA | Corteva | PairCorr |
The ability to find closely correlated positions to Yield10 Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Yield10 Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Yield10 Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Yield10 Bioscience to buy it.
The correlation of Yield10 Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Yield10 Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Yield10 Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Yield10 Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Yield10 Stock
If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |